Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closure

Canadian Cancer Trials Group SRC.5/SWOG S0502-- A Phase III Randomized Study of Imatinib, with or without Bevacizumab (NSC-704865), in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors -- was closed to accrual 18 September 2009.

http://www.ctg.queensu.ca/trials/sarcoma/src5/src5.html